会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Exosomal Biomarkers for Cardiovasular Events
    • 用于心血管事件的Exosomal Biomarkers
    • US20140024046A1
    • 2014-01-23
    • US13995760
    • 2012-02-17
    • Dominique De KleijnGerard PasterkampLeonardus TimmersSiu Kwan Sze
    • Dominique De KleijnGerard PasterkampLeonardus TimmersSiu Kwan Sze
    • G01N33/68
    • G01N33/6893G01N2800/32G01N2800/50G01N2800/52
    • The present invention relates to a method of predicting the risk of a subject developing a cardiovascular event, comprising determining the presence of a biomarker that is indicative of the risk of developing a cardiovascular event in an exosome sample from the subject. The exosomes are suitably isolated from a body fluid selected from serum, plasma, blood, urine, amniotic fluid, malignant ascites, bronchoalveolar lavage fluid, synovial fluid, breast milk, saliva, in particular serum. Alternatively, the exosomes are present in a body fluid, in particular serum. The biomarker is selected from the proteins Vitronectin, Serpin F2, CD14, Cystatin C, Plasminogen, Nidogen 2, Serpin G1 or any combination of two or more of these proteins. The invention further relates to a method of diagnosing the occurrence of acute coronary syndrome in a subject, comprising determining the presence of a biomarker that is indicative of the occurrence of acute coronary syndrome in an exosome sample from the subject. In this method the biomarker is selected from Serpin F2, CD14, Cystatin C or combinations thereof.
    • 本发明涉及一种预测发展心血管事件的受试者的风险的方法,包括确定生物标志物的存在,所述生物标志物指示在来自受试者的外来体样品中发生心血管事件的风险。 外来体合适地从选自血清,血浆,血液,尿液,羊水,恶性腹水,支气管肺泡灌洗液,滑液,母乳,唾液,特别是血清中的体液分离。 或者,外来体存在于体液中,特别是血清中。 生物标志物选自蛋白质Vitronectin,Serpin F2,CD14,半胱氨酸蛋白酶抑制剂C,纤溶酶原,Nidogen 2,Serpin G1或两种或更多种这些蛋白质的任何组合。 本发明还涉及一种诊断受试者中急性冠状动脉综合征发生的方法,包括确定在来自受试者的外来体样品中指示急性冠状动脉综合征发生的生物标志物的存在。 在该方法中,生物标志物选自Serpin F2,CD14,半胱氨酸蛋白酶抑制剂C或其组合。